71 related articles for article (PubMed ID: 15849401)
21. Increased prevalence of human parvovirus B19 DNA in systemic sclerosis skin.
Ohtsuka T; Yamazaki S
Br J Dermatol; 2004 Jun; 150(6):1091-5. PubMed ID: 15214893
[TBL] [Abstract][Full Text] [Related]
22. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy.
Lindblom A; Heyman M; Gustafsson I; Norbeck O; Kaldensjö T; Vernby A; Henter JI; Tolfvenstam T; Broliden K
Clin Infect Dis; 2008 Feb; 46(4):528-36. PubMed ID: 18194100
[TBL] [Abstract][Full Text] [Related]
23. Incidence and clinical significance of parvovirus B19 infection in patients with rheumatoid arthritis.
Kozireva SV; Zestkova JV; Mikazane HJ; Kadisa AL; Kakurina NA; Lejnieks AA; Danilane IN; Murovska MF
J Rheumatol; 2008 Jul; 35(7):1265-70. PubMed ID: 18484700
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of the Roche LightCycler parvovirus B19 quantification kit for the diagnosis of parvovirus B19 infections.
Braham S; Gandhi J; Beard S; Cohen B
J Clin Virol; 2004 Sep; 31(1):5-10. PubMed ID: 15288606
[TBL] [Abstract][Full Text] [Related]
25. Human parvovirus B19 associated with idiopathic thrombocytopenic purpura.
Aktepe OC; Yetgin S; Olcay L; Ozbek N
Pediatr Hematol Oncol; 2004; 21(5):421-6. PubMed ID: 15205085
[TBL] [Abstract][Full Text] [Related]
26. [Parvovirus B19 among blood donors from three hospitals in Santiago, Chile].
Lévican J; Torres M; Gaggero N; Corvalán R; Gaggero A
Rev Med Chil; 2011 Feb; 139(2):143-9. PubMed ID: 21773649
[TBL] [Abstract][Full Text] [Related]
27. Prevalence of antihuman parvovirus B19 IgG antibodies in patients with refractory rheumatoid arthritis and polyarticular juvenile rheumatoid arthritis.
Mimori A; Misaki Y; Hachiya T; Ito K; Kano S
Rheumatol Int; 1994; 14(3):87-90. PubMed ID: 7839075
[TBL] [Abstract][Full Text] [Related]
28. [Parvovirus B19 infection--an incidious chameleon].
Broliden K; Tolfvenstam T; Papadogiannakis N; Westgren M; Matt P; Lundqvist A; Skjöldebrand-Sparre L; Nyman M; Henter JI
Tidsskr Nor Laegeforen; 2000 Feb; 120(4):455-8. PubMed ID: 10833936
[TBL] [Abstract][Full Text] [Related]
29. Antibody response to B19 parvovirus VP1 and VP2 linear epitopes in patients with haemophilic arthritis.
Azzi A; Manaresi E; Zakrzewska K; DeSantis R; Musiani M; Zerbini M
J Med Virol; 2004 Apr; 72(4):679-82. PubMed ID: 14981773
[TBL] [Abstract][Full Text] [Related]
30. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR).
Knöll A; Louwen F; Kochanowski B; Plentz A; Stüssel J; Beckenlehner K; Jilg W; Modrow S
J Med Virol; 2002 Jun; 67(2):259-66. PubMed ID: 11992588
[TBL] [Abstract][Full Text] [Related]
31. [Research on Parvovirus B19 infections and chronic articular manifestations in a Tunisian hospital].
Regaya F; Khelifa R; Zouari R; Kchir M; Karoui M; Essid R
Arch Inst Pasteur Tunis; 2003; 80(1-4):9-15. PubMed ID: 15941063
[TBL] [Abstract][Full Text] [Related]
32. [Parvovirus B19 as a cause of acute liver symptoms in adults].
Hillingsø JG; Jensen IP; Tom-Petersen L
Ugeskr Laeger; 1998 Oct; 160(44):6355-6. PubMed ID: 9810242
[TBL] [Abstract][Full Text] [Related]
33. Detection of human parvovirus B19 in early spontaneous abortuses using serology, histology, electron microscopy, in situ hybridization, and the polymerase chain reaction.
Rogers BB; Singer DB; Mak SK; Gary GW; Fikrig MK; McMillan PN
Obstet Gynecol; 1993 Mar; 81(3):402-8. PubMed ID: 8437795
[TBL] [Abstract][Full Text] [Related]
34. Childhood idiopathic thrombocytopenic purpura: association with human parvovirus B19 infection.
Murray JC; Kelley PK; Hogrefe WR; McClain KL
Am J Pediatr Hematol Oncol; 1994 Nov; 16(4):314-9. PubMed ID: 7978048
[TBL] [Abstract][Full Text] [Related]
35. Chronic fatigue syndrome and arthralgia following parvovirus B19 infection.
Kerr JR; Bracewell J; Laing I; Mattey DL; Bernstein RM; Bruce IN; Tyrrell DA
J Rheumatol; 2002 Mar; 29(3):595-602. PubMed ID: 11911112
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of human parvovirus B19 DNA in cardiac tissues of patients with congenital heart diseases indicated by nested PCR and in situ hybridization.
Wang X; Zhang G; Liu F; Han M; Xu D; Zang Y
J Clin Virol; 2004 Sep; 31(1):20-4. PubMed ID: 15288609
[TBL] [Abstract][Full Text] [Related]
37. The cutaneous manifestations of human parvovirus B19 infection.
Magro CM; Dawood MR; Crowson AN
Hum Pathol; 2000 Apr; 31(4):488-97. PubMed ID: 10821497
[TBL] [Abstract][Full Text] [Related]
38. [Diagnosis of parvovirus B19 infection in hematological patients with partial red cell aplasia of the bone marrow].
Iaguzhinskaia OE; Pivnik AV; Fevraleva IS; Sudarikov AB; Lisovina IuS; Loginova IV; Shitareva IV
Ter Arkh; 2001; 73(8):50-6. PubMed ID: 11599268
[TBL] [Abstract][Full Text] [Related]
39. Serological and virological markers of human parvovirus B19 infection in sera of hemophiliacs.
Grosse-Bley A; Eis-Hübinger AM; Kaiser R; Oldenburg J; Brackmann HH; Schwarz TF; Schneweis KE
Thromb Haemost; 1994 Oct; 72(4):503-7. PubMed ID: 7878623
[TBL] [Abstract][Full Text] [Related]
40. Is routine viral screening useful in patients with recent-onset polyarthritis of a duration of at least 6 weeks? Results from a nationwide longitudinal prospective cohort study.
Varache S; Narbonne V; Jousse-Joulin S; Guennoc X; Dougados M; Daurès JP; Devauchelle-Pensec V; Saraux A
Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1565-70. PubMed ID: 21954118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
